Allos, FDA agree on cancer drug trial design (Reuters)

Reuters - Allos Therapeutics Inc said it agreed with the U.S. health regulator on the trial design for a late-stage study of the company's cancer drug.

Source: http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20110303/hl_nm/us_allos

health food weight lifting